Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.

Hasebe M, Su CY, Yabe D, Yoshiji S

Open source

DOI
10.1111/dom.71035
Published
2026 Sep
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71035,
  title = {Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.},
  author = {Hasebe M and Su CY and Yabe D and Yoshiji S},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71035},
  url = {https://doi.org/10.1111/dom.71035}
}

RIS

TY  - JOUR
TI  - Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.
AU  - Hasebe M
AU  - Su CY
AU  - Yabe D
AU  - Yoshiji S
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71035
UR  - https://doi.org/10.1111/dom.71035
ER  - 

APA

M, H., CY, S., D, Y., & S, Y. (2026). Cardiovascular Efficacy of GLP-1 Receptor Agonists by Kidney Function: An Updated Meta-Analysis of Randomized Trials Including the SOUL Trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71035

Source records